| A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts I Pabinger, N van Es, G Heinze, F Posch, J Riedl, EM Reitter, M Di Nisio, ... The Lancet Haematology 5 (7), e289-e298, 2018 | 324 | 2018 |
| Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism J Riedl, M Preusser, PMS Nazari, F Posch, S Panzer, C Marosi, P Birner, ... Blood, The Journal of the American Society of Hematology 129 (13), 1831-1839, 2017 | 229 | 2017 |
| Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer J Riedl, A Kaider, EM Reitter, C Marosi, U Jäger, I Schwarzinger, ... Thrombosis and haemostasis 111 (04), 670-678, 2014 | 126 | 2014 |
| Platelets in cancer and thrombosis J Riedl, I Pabinger, C Ay Hämostaseologie 34 (01), 54-62, 2014 | 122 | 2014 |
| Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality J Riedl, F Posch, O Königsbrügge, F Lötsch, EM Reitter, E Eigenbauer, ... PloS one 9 (10), e111440, 2014 | 103 | 2014 |
| Association between decreased serum albumin with risk of venous thromboembolism and mortality in cancer patients O Königsbrügge, F Posch, J Riedl, EM Reitter, C Zielinski, I Pabinger, ... The oncologist 21 (2), 252-257, 2016 | 88 | 2016 |
| Hypercoagulabilty, venous thromboembolism, and death in patients with cancer F Posch, J Riedl, EM Reitter, A Kaider, C Zielinski, I Pabinger, C Ay Thrombosis and haemostasis 115 (04), 817-826, 2016 | 82 | 2016 |
| Association of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with the risk of thromboembolism and mortality in patients with cancer E Grilz, F Posch, O Königsbrügge, I Schwarzinger, IM Lang, C Marosi, ... Thrombosis and haemostasis 118 (11), 1875-1884, 2018 | 63 | 2018 |
| Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis T Gremmel, C Ay, J Riedl, CW Kopp, B Eichelberger, R Koppensteiner, ... Thrombosis and haemostasis 115 (03), 615-621, 2016 | 61 | 2016 |
| Venous thromboembolism in brain tumors: risk factors, molecular mechanisms, and clinical challenges J Riedl, C Ay Seminars in thrombosis and hemostasis 45 (04), 334-341, 2019 | 60 | 2019 |
| Association of platelet activation markers with cancer-associated venous thromboembolism J Riedl, L Hell, A Kaider, S Koder, C Marosi, C Zielinski, S Panzer, ... Platelets 27 (1), 80-85, 2016 | 57 | 2016 |
| Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D‐Dimer analysis: A prospective study F Posch, J Riedl, EM Reitter, MJ Crowther, E Grilz, P Quehenberger, ... Journal of Thrombosis and Haemostasis 18 (6), 1348-1356, 2020 | 53 | 2020 |
| The role of ADAMTS‐13 and von Willebrand factor in cancer patients: results from the Vienna cancer and thrombosis study HL Obermeier, J Riedl, C Ay, S Koder, P Quehenberger, R Bartsch, ... Research and Practice in Thrombosis and Haemostasis 3 (3), 503-514, 2019 | 53 | 2019 |
| Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis J Riedl, A Kaider, C Marosi, GW Prager, B Eichelberger, A Assinger, ... Thrombosis and haemostasis 26 (01), 90-98, 2017 | 52 | 2017 |
| Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous … P Mir Seyed Nazari, J Riedl, M Preusser, F Posch, J Thaler, C Marosi, ... Journal of Thrombosis and Haemostasis 16 (6), 1121-1127, 2018 | 47 | 2018 |
| The role of podoplanin in cancer-associated thrombosis PMS Nazari, J Riedl, I Pabinger, C Ay Thrombosis Research 164, S34-S39, 2018 | 46 | 2018 |
| Alterations of blood coagulation in controlled human malaria infection J Riedl, B Mordmüller, S Koder, I Pabinger, PG Kremsner, SL Hoffman, ... Malaria journal 15, 1-7, 2016 | 44 | 2016 |
| Association of complete blood count parameters, d‐dimer, and soluble P‐selectin with risk of arterial thromboembolism in patients with cancer E Grilz, C Marosi, O Königsbrügge, J Riedl, F Posch, W Lamm, IM Lang, ... Journal of Thrombosis and Haemostasis 17 (8), 1335-1344, 2019 | 37 | 2019 |
| Risk assessment scores for cancer-associated venous thromboembolic disease D Angelini, AA Khorana Seminars in thrombosis and hemostasis 43 (05), 469-478, 2017 | 34 | 2017 |
| Multistate models: accurate and dynamic methods to improve predictions of thrombotic risk in patients with cancer A Carmona-Bayonas, P Jimenez-Fonseca, M Garrido, A Custodio, ... Thrombosis and Haemostasis 119 (11), 1849-1859, 2019 | 32 | 2019 |